share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Greene John

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Greene John

CRISPR Therapeutics | 4：持股變動聲明-董事 Greene John
美股sec公告 ·  05/31 16:21
Moomoo AI 已提取核心訊息
In a recent transaction, John Greene, associated with CRISPR Therapeutics (CRSP.US), executed a stock action on 05/30/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-action shareholding, were not disclosed in the announcement. Investors are advised to monitor CRISPR Therapeutics for any further disclosures that may provide additional insights into the transaction's impact on the company's stock.
In a recent transaction, John Greene, associated with CRISPR Therapeutics (CRSP.US), executed a stock action on 05/30/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-action shareholding, were not disclosed in the announcement. Investors are advised to monitor CRISPR Therapeutics for any further disclosures that may provide additional insights into the transaction's impact on the company's stock.
在最近的一筆交易中，與CRISPR Therapeutics（CRSP.US）相關的約翰·格林於2024年5月30日執行了股票行動。公告中未披露該交易的具體細節，包括行動類型、狀態、所涉股份數量、股票性質、交易價格和事後持股。建議投資者關注CRISPR Therapeutics是否有任何進一步的披露，這些披露可能爲該交易對公司股票的影響提供更多見解。
在最近的一筆交易中，與CRISPR Therapeutics（CRSP.US）相關的約翰·格林於2024年5月30日執行了股票行動。公告中未披露該交易的具體細節，包括行動類型、狀態、所涉股份數量、股票性質、交易價格和事後持股。建議投資者關注CRISPR Therapeutics是否有任何進一步的披露，這些披露可能爲該交易對公司股票的影響提供更多見解。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息